[Antimicrobial activities of clavulanic acid/ticarcillin against clinical isolates]. 1995

M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
Section of Studies, Tokyo Clinical Research Center.

In order to investigate antimicrobial activities of clavulanic acid/ticarcillin (CVA/TIPC) against Escherichia coli, Enterobacter spp. and Pseudomonas aeruginosa in 1992 and 1994, beta-lactamase activities were analyzed and minimum inhibitory concentrations (MICs) were determined including those of the control drugs. The results are as follows; 1. Compared to a report in 1980, the MIC distributions of CVA/TIPC against E. coli and P. aeruginosa did not show large differences. We found, however, that CVA/TIPC-resistant strains increased among Enterobacter spp. 2. Almost all of CVA/TIPC-resistant strains of Enterobacter spp. were also resistant to cephems and new quinolones, thus they were multiple drug resistant. 3. CVA/TIPC showed strong antimicrobial activities against penicillinase producing E. coli.

UI MeSH Term Description Entries
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002969 Clavulanic Acids Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects. Acids, Clavulanic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004754 Enterobacter Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
July 1989, Journal of chemotherapy (Florence, Italy),
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
March 1984, Antimicrobial agents and chemotherapy,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
November 1986, The New Zealand medical journal,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
October 1986, The Journal of antibiotics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
August 1985, The Medical letter on drugs and therapeutics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
August 1985, Clinical pharmacology and therapeutics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
August 1978, Antimicrobial agents and chemotherapy,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
October 1990, The Journal of antimicrobial chemotherapy,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
January 1989, Diagnostic microbiology and infectious disease,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
May 1985, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!